BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹2.71 Cr | ₹0.37 Cr | ₹0.09 Cr | ₹0.17 Cr | ₹-1.44 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAL PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹2.71 Cr |
Mar2023 | ₹0.37 Cr |
Mar2022 | ₹0.09 Cr |
Mar2021 | ₹0.17 Cr |
Mar2020 | ₹-1.44 Cr |
How is Net Cash Inflow / Outflow of BAL PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹2.71 Cr | 624.33 | |
Mar2023 | ₹0.37 Cr | 320.22 | |
Mar2022 | ₹0.09 Cr | -47.02 | |
Mar2021 | ₹0.17 Cr | Positive | |
Mar2020 | ₹-1.44 Cr | - |
Compare Net Cash Inflow / Outflow of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹191.7 Cr | -1.2% | -4.2% | 13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -1.2% |
-4.2% |
13.1% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses